Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DNC006929

Drug Information
IndicationNot AvailableExperimental    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESC1=CC(=O)C=CC1=NNC2=C(NN=C2N)N    
TargetCasein kinase II alphaInhibitor[1]
Cyclin T1Inhibitor[1]
Cyclin-dependent kinase 2Inhibitor[1]
Cyclin-dependent kinase 4Inhibitor[1]
Cyclin-dependent kinase 9Inhibitor[1]
G1/S-specific cyclin D1Inhibitor[1]
G1/S-specific cyclin E2Inhibitor[1]
Glycogen synthase kinase-3 betaInhibitor[1]
MAP kinase ERK2Inhibitor[1]
MAP kinase p38 alphaInhibitor[1]
Ribosomal protein S6 kinase 2Inhibitor[1]
Serine/threonine-protein kinase AKTInhibitor[1]
Serine/threonine-protein kinase Chk1 Inhibitor[1]
Tyrosine-protein kinase ABLInhibitor[1]
cAMP-dependent protein kinase alpha-catalytic subunitInhibitor[1]
cAMP-dependent protein kinase beta-1 catalytic subunitInhibitor[1]
cAMP-dependent protein kinase, gamma catalytic subunitInhibitor[1]
Ref 1J Med Chem. 2006 Nov 2;49(22):6500-9.4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543